ストックスクリーナーアプリを入手
0.1581
6.75%
0.010
プレマーケット:
.16
0.0019
+1.20%
Bioatla Inc (BCAB) 最新ニュース
Buyout Rumor: Can BioAtla Inc deliver consistent dividends2026 Decliners & Risk Managed Investment Signals - baoquankhu1.vn
BioAtla, Inc. 8-K SEC Filing March 17, 2026: Company Information, Key Details, and Legal Disclosures - Minichart
BioAtla Shareholders Approve Merger and Share Consolidation - TipRanks
BioAtla (NASDAQ: BCAB) approves merger, 1-for-50 reverse split and 2026 executive retention bonuses - Stock Titan
842,440 shares issued to YA II PN, Ltd.; BioAtla (NASDAQ: BCAB) registers resale - Stock Titan
BCAB Stock Price, Quote & Chart | BIOATLA INC (NASDAQ:BCAB) - ChartMill
Breakout Watch: What is the dividend yield of BioAtla IncEarnings Growth Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
BCAB Technical Analysis | Trend, Signals & Chart Patterns | BIOATLA INC (NASDAQ:BCAB) - ChartMill
BioAtla (NASDAQ: BCAB) to issue 631,163 shares to Yorkville under SEPA - Stock Titan
BioAtla (NASDAQ: BCAB) CMO receives 240,000-share time-based RSU award - Stock Titan
BioAtla (NASDAQ: BCAB) CEO receives 430,000-share RSU grant - Stock Titan
BioAtla (BCAB) CFO awarded 240,000 restricted stock units, total holdings 530,196 shares - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Published on: 2026-03-07 14:29:43 - Naître et grandir
BioAtla launches major restructuring and leadership transition - The Globe and Mail
BioAtla explores sale as it cuts 70% of workforce - Investing.com South Africa
BioAtla (BCAB) CFO sees 1,802 shares withheld for RSU tax settlement - Stock Titan
[Form 4] BioAtla, Inc. Insider Trading Activity - Stock Titan
BioAtla (BCAB) CMO reports 3,140-share tax withholding on RSU vesting - Stock Titan
BioAtla explores sale as it cuts 70% of workforce By Investing.com - Investing.com India
BioAtla, Inc. Initiates Strategic Review Process and Workforce Restructuring to Enhance Shareholder Value - Quiver Quantitative
BioAtla Inc announces 70% workforce reductionSEC filing - marketscreener.com
BioAtla appoints Chris Vasquez as CFO as Richard Waldron departs - TradingView
BioAtla (NASDAQ: BCAB) slashes workforce 70% amid strategic review, listing risk - Stock Titan
BioAtla, Inc. Implements Workforce Reduction of Approximately 70% - marketscreener.com
Bioatla announces formal process to evaluate strategic options to monetize assets - marketscreener.com
Bioatla Announces Formal Process To Evaluate Strategic Options To Monetize Assets - TradingView
Biotech BioAtla to shed 70% of staff while weighing asset sales - Stock Titan
Bioatla, Inc. Announces CFO Changes. Effective March 2, 2026 - marketscreener.com
BCAB PE Ratio & Valuation, Is BCAB Overvalued - Intellectia AI
US Market Wrap: Does BioAtla Inc meet Warren Buffetts criteria2025 Retail Activity & Low Drawdown Momentum Ideas - baoquankhu1.vn
Aug Sentiment: Is BioAtla Inc forming bullish engulfing patterns2025 Geopolitical Influence & Long-Term Safe Return Strategies - baoquankhu1.vn
BioAtla, Inc. (NASDAQ:BCAB) Sees Large Drop in Short Interest - Defense World
BioAtla (BCAB) CEO has shares withheld to cover RSU taxes - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BioAtla to Participate in the Citizens Life Sciences Conference - 富途牛牛
Gap Down: Will BioAtla Inc stock hit new highs in YEAR2025 Bull vs Bear & Accurate Intraday Trading Signals - baoquankhu1.vn
BCABBioatla, Inc. Latest Stock News & Market Updates - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Aug Chart Watch: Will Nixxy Inc Equity Warrant outperform its industry peers2025 Trading Volume Trends & Accurate Buy Signal Alerts - baoquankhu1.vn
Why BioAtla Inc. stock is popular among millennials2025 Pullback Review & Entry and Exit Point Strategies - mfd.ru
What analysts say about BioAtla Inc. stockJuly 2025 Review & Growth Focused Stock Reports - mfd.ru
BCAB Should I Buy - Intellectia AI
BioAtla Sets March Virtual Vote on Internal Merger Plan - The Globe and Mail
Why BioAtla Inc. stock could see breakout soonSell Signal & Community Consensus Picks - mfd.ru
BioAtla (BCAB) seeks approval for 1‑for‑50 share conversion to support Nasdaq listing - Stock Titan
Bioatla Faces Nasdaq Delisting Review Amid Corporate Restructuring - AD HOC NEWS
Is BioAtla Inc. currently under institutional pressureQuarterly Risk Review & Technical Analysis for Trade Confirmation - mfd.ru
BioAtla Faces Nasdaq Review of Continued Listing Status - The Globe and Mail
BioAtla to remain on Nasdaq during listing council review process By Investing.com - Investing.com Canada
BioAtla to remain on Nasdaq during listing council review process - Investing.com Nigeria
BioAtla Faces Nasdaq Delisting Review - TradingView
Why STMicroelectronics Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
BioAtla Faces Nasdaq Trading Suspension and Potential Delisting - The Globe and Mail
BioAtla to be suspended from Nasdaq after delisting determination By Investing.com - Investing.com Nigeria
BioAtla to be suspended from Nasdaq after delisting determination - Investing.com
BioAtla Received Notice of Delisting - TradingView
Activity Recap: Will BioAtla Inc benefit from AI trends2025 Biggest Moves & Precise Buy Zone Tips - baoquankhu1.vn
1.82%
大文字化:
|
ボリューム (24 時間):